Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06515327

Effects of Corticosteroid Use on Restoration of Spontaneous Circulation in Cardiac Arrest Patients

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
46 (estimated)
Sponsor
Saglik Bilimleri Universitesi · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

We aim to investigate the effects of pre-arrest corticosteroid use for any reason on the time of return of spontaneous circulation in patients experiencing witnessed cardiac arrest, either in-hospital or out-of-hospital. Additionally, we plan to study the effects of corticosteroid use on post-ROSC administration of vasoactive agents, required dosage of vasoactive agents and number of vasoactive agents needed in order to reach targeted blood pressure levels.

Detailed description

Patients will be collected from Etlik City Hospital Emergency Medicine Department. Patients presenting with witnessed cardiac arrest, either in-hospital or out-of-hospital, will be enrolled in our study. Inclusion Criteria: Age 18 and above Witnessed cardiac arrest Exclusion Criteria: Traumatic cardiac arrest Forensic cases Cardiac arrest secondary to ST-elevation myocardial infarction Patients in whom spontaneous circulation could not be achieved despite cardiopulmonary resuscitation lasting more than 20 minutes Patients with inaccessible past medical records or unknown medication history Patients without identification Unwitnessed cardiac arrest Pregnant patients Patients will be divided into two groups: The first group will consist of 23 patients who used corticosteroid medications for any reason before experiencing cardiac arrest. The second group will consist of 23 patients who did not use corticosteroid medications before cardiac arrest. Following successful cardiopulmonary resuscitation and restoration of spontaneous circulation, the following parameters will be recorded for both groups: need for vasopressor support, number of vasopressor agents used, maximum dose of vasopressor agent(s) required to maintain mean arterial pressure (MAP) \>65 mmHg, duration of stay in intensive care unit/emergency department, mortality rate, length of hospital stay, patients' medical histories, age, and gender. These parameters will be compared between the corticosteroid-using and non-using groups, and statistical analysis will be conducted to evaluate differences between the two groups

Conditions

Timeline

Start date
2024-08-01
Primary completion
2025-08-01
Completion
2025-08-01
First posted
2024-07-23
Last updated
2024-07-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06515327. Inclusion in this directory is not an endorsement.